Common adverse effects include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, particularly during the dose-escalation phase
Access this article Similar content being viewed by others References Papers of particular interest, published recently, have been highlighted as: Of importance Of major importance Di Angelantonio E, Kaptoge S, Wormser D, et al
Summary Basis of Decision for Ozempic Government of Canada What you need to know about Ozempic Alberta Blue Cross Novo Nordisk prepares new cheaper version of Ozempic as generics face delays The Globe And Mail Diabetes Canada stresses it doesn't endorse medical products after ads suggest otherwise CBC
Again, data on the long-term effects of melanotan 2 is unavailable